[Pharmacological regulation of emotional stress reactions].
Seredenin
S B
SB
D000328:Adult; D000818:Animals; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001562:Benzimidazoles / Q000008:administration & dosage / Q000627:therapeutic use; D001569:Benzodiazepines / Q000008:administration & dosage / Q000627:therapeutic use; D004151:Dipeptides / Q000008:administration & dosage / Q000627:therapeutic use; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000627:therapeutic use; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009025:Morpholines / Q000008:administration & dosage / Q000627:therapeutic use; D010551:Personality; D051381:Rats; D011919:Rats, Inbred Strains; D013315:Stress, Psychological / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000627:therapeutic use
C410924:2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole; D014151:Anti-Anxiety Agents; D001562:Benzimidazoles; D004151:Dipeptides; D006993:Hypnotics and Sedatives; D009025:Morpholines; D014149:Tranquilizing Agents; D001569:Benzodiazepines; C103871:ethyl phenylacetyl-Pro-Gly; C077010:gidazepam